My research integrates neuropharmacology, molecular genetics, and cognitive neuropsychology to elucidate mechanisms of neurodegenerative disorders, cancer, and stress-related pathologies. Adopting a systems biology approach, I investigate natural bioactive metabolites, microbiome–gut–brain axis interactions, genetic variants, and psychosocial modifiers, aiming to translate mechanistic insights into preventive and precision therapeutic interventions.
Natural Products as Modulators of Neurodegeneration
My research focuses on the extraction, isolation, structural characterization, and pharmacological evaluation of phytochemicals from medicinal plants. Utilizing in vitro biochemical assays, in silico molecular docking, molecular dynamics simulations, and cell-based models, I characterize their multimodal activities, including antimicrobial (against Gram-positive/negative pathogens), antioxidant, anti-inflammatory, anticancer, anti-aggregative (e.g., inhibition of tau and amyloid-β fibrillization), and neuroprotective effects. These properties position such compounds as promising multitarget leads for Alzheimer’s disease and tauopathies, addressing oxidative stress, neuroinflammation, protein misfolding, and aggregation—key hallmarks of neurodegeneration.
This work aligns with emerging evidence that phytochemicals exert broad-spectrum protective effects through interconnected mechanisms, such as radical scavenging, modulation of inflammatory pathways (e.g., NF-κB suppression), enhancement of mitochondrial function, and direct interference with pathogenic protein aggregation.
Genetic and Molecular Basis of Neurodegenerative Disorders
I investigate pathogenic variants in key genes (e.g., TRIM74, MARK4) that induce protein misfolding, proteotoxic stress, synaptic impairment, and neuronal loss. Integrating whole-exome sequencing, structural bioinformatics, molecular dynamics, and functional assays, my studies delineate genotype–phenotype correlations and support targeted precision medicine strategies for complex neurological conditions.
Cognitive Neuropsychology and Stress–Microbiome–Brain Interactions
Current efforts examine how psychosocial stress (e.g., academic pressure), early-life events (e.g., pubertal timing), and microbiome dynamics modulate cognitive trajectories, mental health, and susceptibility to neurodegeneration across the lifespan. This multidisciplinary framework identifies modifiable risk/resilience factors to guide evidence-based prevention and public health interventions.